SynopsisThe global Abemaciclib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Abemaciclib is estimated to increase from $ million in.....
SynopsisThe global Talazoparib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Talazoparib is estimated to increase from $ million in.....
SynopsisThe global Pomalidomide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Pomalidomide is estimated to increase from $ million .....
SynopsisThe global Ixazomib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Ixazomib is estimated to increase from $ million in 2023 .....
SynopsisThe global Elotuzumab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Elotuzumab is estimated to increase from $ million in 2.....
SynopsisThe global Carmustine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Carmustine is estimated to increase from $ million in 2.....
SynopsisThe global Gefitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Gefitinib is estimated to increase from $ million in 202.....
SynopsisThe global Afatinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Afatinib is estimated to increase from $ million in 2023 .....
SynopsisThe global Indacaterol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Indacaterol is estimated to increase from $ million in.....
SynopsisThe global Siltuximab market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Siltuximab is estimated to increase from $ million in 2.....
